Biocon Limited's momentum is stalling.
There was a modification in the price predictions for Biocon Limited (BIOCON) as of 2024-03-18.
In their thorough research evaluations, analysts outline a price band for a particular stock, providing investors with essential guidance for their investment choices. Based on the analysis of 19 leading analysts, BIOCON's anticipated price is estimated to fluctuate between 200.0 and 355.0, with the mean forecast settling near 279.32.
Market expectations for BIOCON's earnings changed on 2024-03-18, as it approaches its next results.
Meeting or exceeding earnings estimates can enhance investor confidence in a company's management and business fundamentals, positively impacting its stock price and reputation. Average revenue has been revised down to 145841000000. Previously, it was 148413000000. These figure are based on the prediction of 16 analysts.
The average EPS (yearly) is expected to be at 6.1 for the period ending on 31-03-2024 between expected lower and upper bands at 2.1 and 9.0 respectively. This is an increase of about 0.589 from the EPS of 3.84 from a year ago. Similarly the average revenue is expected to be at 145841000000 between expected lower and upper bands at 142332000000 and 153420000000 respectively. As compared to the revenue of 19929000000 from a year ago, the current estimate indicates an increase of roughly 6.318
The escalation in earnings estimates has the potential to boost prices ahead of the upcoming results, allowing investors to enter early.
Technical Summary
The current price of 256.6 finds support at 245.7 and resistance at 257.9. The recent price move is approaching resistance.
The PSAR continues its bearish outlook and sets a level of resistance.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word: